Literature DB >> 18588940

The role of reactive oxygen species in arsenite and monomethylarsonous acid-induced signal transduction in human bladder cells: acute studies.

K E Eblin1, A M Hau, T J Jensen, B W Futscher, A J Gandolfi.   

Abstract

Arsenicals are known to induce ROS, which can lead to DNA damage, oxidative stress, and carcinogenesis. A human urothelial cell line, UROtsa, was used to study the effects of arsenicals on the human bladder. Arsenite [As(III)] and monomethylarsonous acid [MMA(III)] induce oxidative stress in UROtsa cells after exposure to concentrations as low as 1 microM and 50 nM, respectively. Previous research has implicated ROS as signaling molecules in the MAPK signaling pathway. As(III) and MMA(III) have been shown to increase phosphorylation of key proteins in the MAPK signaling cascade downstream of ErbB2. Both Src phosphorylation (p-Src) and cyclooxygenase-2 (COX-2) are induced after exposure to 50 nM MMA(III) and 1 microM As(III). These data suggest that ROS production is a plausible mechanism for the signaling alterations seen in UROtsa cells after acute arsenical exposure. To determine importance of ROS in the MAPK cascade and its downstream induction of p-Src and COX-2, specific ROS antioxidants (both enzymatic and non-enzymatic) were used concomitantly with arsenicals. COX-2 protein and mRNA was shown to be much more influenced by altering the levels of ROS in cells, particularly after MMA(III) treatment. The antioxidant enzyme superoxide dismutase (SOD) effectively blocked both As(III)-and MMA(III)- associated COX-2 induction. The generation of ROS and subsequent altered signaling did lead to changes in protein levels of SOD, which were detected after treatment with either 1 microM As(III) or 50 nM MMA(III). These data suggest that the generation of ROS by arsenicals may be a mechanism leading to the altered cellular signaling seen after low-level arsenical exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588940      PMCID: PMC2567114          DOI: 10.1016/j.tox.2008.05.018

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  39 in total

1.  Possible beneficial effects of melatonin supplementation on arsenic-induced oxidative stress in Wistar rats.

Authors:  Sudipta Pal; Ajay K Chatterjee
Journal:  Drug Chem Toxicol       Date:  2006       Impact factor: 3.356

2.  Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.

Authors:  Pankaj Wadhwa; Anil K Goswami; Kusum Joshi; Surinder K Sharma
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Antioxidant capacity of the neurohormone melatonin.

Authors:  E Sofic; Z Rimpapa; Z Kundurovic; A Sapcanin; I Tahirovic; A Rustembegovic; G Cao
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

Review 4.  Arsenic-induced bladder cancer in an animal model.

Authors:  Samuel M Cohen; Takamasa Ohnishi; Lora L Arnold; X Chris Le
Journal:  Toxicol Appl Pharmacol       Date:  2006-10-17       Impact factor: 4.219

5.  Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.

Authors:  Kylee E Eblin; Tiffany G Bredfeldt; Sarah Buffington; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2006-11-08       Impact factor: 4.849

6.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

7.  Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder.

Authors:  Anna Kinoshita; Hideki Wanibuchi; Min Wei; Takayuki Yunoki; Shoji Fukushima
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-30       Impact factor: 4.219

8.  Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer.

Authors:  Tzyh-Chyuan Hour; Yeong-Shiau Pu; Chia-Chi Lin; Shi-Wei Huang; Jun Chen; Allen W Chiu; Chien-Jen Chen; Chao-Yuan Huang
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

Review 9.  Oxidative stress as a possible mode of action for arsenic carcinogenesis.

Authors:  Kirk T Kitchin; Sarfaraz Ahmad
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

10.  Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water.

Authors:  Jingbo Pi; Hiroshi Yamauchi; Yoshito Kumagai; Guifan Sun; Takahiko Yoshida; Hiroyuki Aikawa; Claudia Hopenhayn-Rich; Nobuhiro Shimojo
Journal:  Environ Health Perspect       Date:  2002-04       Impact factor: 9.031

View more
  11 in total

Review 1.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

2.  Arsenite Targets the RING Finger Domain of Rbx1 E3 Ubiquitin Ligase to Inhibit Proteasome-Mediated Degradation of Nrf2.

Authors:  Ji Jiang; Lok Ming Tam; Pengcheng Wang; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2018-04-23       Impact factor: 3.739

3.  Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice.

Authors:  Xiaofei Lei; Meng Liu; Zirong Yang; Mengyao Ji; Xufeng Guo; Weiguo Dong
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

4.  Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells.

Authors:  Shawn M Wnek; Christopher L Kuhlman; Jeannie M Camarillo; Matthew K Medeiros; Ke J Liu; Serrine S Lau; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-10       Impact factor: 4.219

5.  Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.

Authors:  Matthew Medeiros; Xinghui Zheng; Petr Novak; Shawn M Wnek; Vivian Chyan; Claudia Escudero-Lourdes; A Jay Gandolfi
Journal:  Toxicology       Date:  2011-11-17       Impact factor: 4.221

6.  Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure.

Authors:  Shawn M Wnek; Taylor J Jensen; Paul L Severson; Bernard W Futscher; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2010-04-07       Impact factor: 4.849

7.  Solid surface photochemistry of montmorillonite: mechanisms for the arsenite oxidation under UV-A irradiation.

Authors:  Yanan Yuan; Yajie Wang; Wei Ding; Jinjun Li; Feng Wu
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-22       Impact factor: 4.223

8.  Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid.

Authors:  S M Wnek; M K Medeiros; K E Eblin; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-20       Impact factor: 4.219

9.  Reactive oxygen species regulate properties of transformation in UROtsa cells exposed to monomethylarsonous acid by modulating MAPK signaling.

Authors:  K E Eblin; T J Jensen; S M Wnek; S E Buffington; B W Futscher; A J Gandolfi
Journal:  Toxicology       Date:  2008-10-22       Impact factor: 4.221

10.  Rbfox2 dissociation from stress granules suppresses cancer progression.

Authors:  Sunkyung Choi; Moa Sa; Namjoon Cho; Kee K Kim; Su-Hyung Park
Journal:  Exp Mol Med       Date:  2019-04-26       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.